X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
oncology (19) 19
female (18) 18
humans (18) 18
breast cancer (16) 16
middle aged (13) 13
adult (12) 12
breast neoplasms - pathology (10) 10
hematology, oncology and palliative medicine (10) 10
aged (9) 9
gastroenterology and hepatology (9) 9
breast neoplasms - drug therapy (8) 8
cancer (8) 8
chemotherapy (7) 7
neoplasm staging (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
breast neoplasms - mortality (6) 6
care and treatment (6) 6
mastectomy (6) 6
obstetrics and gynecology (6) 6
treatment outcome (6) 6
breast neoplasms - therapy (5) 5
disease-free survival (5) 5
docetaxel (5) 5
neoadjuvant therapy (5) 5
oncology, experimental (5) 5
patients (5) 5
research (5) 5
survival (5) 5
women (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
breast neoplasms - metabolism (4) 4
cancer patients (4) 4
carcinoma (4) 4
carcinoma, lobular - mortality (4) 4
neoadjuvant chemotherapy (4) 4
neoplasm metastasis (4) 4
primary therapy (4) 4
prognosis (4) 4
receptors, estrogen - metabolism (4) 4
adjuvant treatment (3) 3
anthracycline (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
biomarkers, tumor - metabolism (3) 3
capecitabine (3) 3
carcinoma, ductal, breast - metabolism (3) 3
carcinoma, ductal, breast - mortality (3) 3
carcinoma, lobular - metabolism (3) 3
carcinoma, lobular - therapy (3) 3
celiac disease (3) 3
chemotherapy, adjuvant - methods (3) 3
clinical trials (3) 3
combined modality therapy (3) 3
cyclophosphamide (3) 3
doxorubicin (3) 3
expression (3) 3
fluorouracil - administration & dosage (3) 3
fluorouracil - adverse effects (3) 3
follow-up studies (3) 3
kaplan-meier estimate (3) 3
letrozole (3) 3
lymphatic metastasis (3) 3
male (3) 3
medical prognosis (3) 3
medicine & public health (3) 3
metastases (3) 3
multicenter (3) 3
nitriles - administration & dosage (3) 3
obstetrics & gynecology (3) 3
patient outcomes (3) 3
primary chemotherapy (3) 3
receptor, erbb-2 - metabolism (3) 3
receptors, progesterone - metabolism (3) 3
retrospective studies (3) 3
triazoles - administration & dosage (3) 3
vinorelbine (3) 3
young adult (3) 3
5-fluorouracil (2) 2
adolescent (2) 2
aged, 80 and over (2) 2
analysis (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - therapeutic use (2) 2
biopsy (2) 2
breast (2) 2
breast neoplasms - classification (2) 2
breast neoplasms - surgery (2) 2
cancer therapies (2) 2
carcinoma, ductal, breast - therapy (2) 2
carcinoma, lobular - classification (2) 2
carcinoma, lobular - pathology (2) 2
chemotherapy, adjuvant (2) 2
cisplatin - administration & dosage (2) 2
cisplatin - adverse effects (2) 2
clinical-implications (2) 2
combination (2) 2
cyclophosphamide - administration & dosage (2) 2
cyclophosphamide - adverse effects (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Letters, ISSN 0304-3835, 2017, Volume 400, pp. 276 - 281
Journal Article
Future Oncology, ISSN 1479-6694, 08/2015, Volume 11, Issue 15s, pp. 23 - 26
Effective treatment options for patients with metastatic breast cancer resistant to anthracyclines and taxanes are limited. Moreover, many chemotherapeutic... 
breast cancer | response | eribulin | MESYLATE | HALICHONDRIN B ANALOG | E7389 | ONCOLOGY | ANTHRACYCLINE | PHASE-II
Journal Article
by Galimberti, Viviana and Cole, Bernard F and Viale, Giuseppe and Veronesi, Paolo and Veronesi, Umberto and Veronesi, Andreas and Vicini, Elisa and Intra, Mattia and Mazzarol, Giovanni and Massarut, Samuele and Zgajnar, Janez and Taffurelli, Mario and Littlejohn, David and Knauer, Michael and Tondini, Carlo and Di Leo, Angelo and Colleoni, Marco and Regan, Meredith M and Coates, Alan S and Gelber, Richard D and Goldhirsch, Aron and Boyle, Fran and Jerusalem, Guy and Stahel, Rolf and Aebi, Stefan and Green, Michael and Karlsson, Per and Kössler, Ingrid and Láng, Istvan and Hiltbrunner, Anita and Bernhard, Jürg and Fournarakou, Stamatina and Kammler, Roswitha and Maibach, Rudolf and Rabaglio, Manuela and Ribi, Karin and Roschitzki, Heidi and Roux, Susanne and Ruepp, Barbara and Mahoney, Caitlin and Price, Karen and Blacher, Lynette and Scolese, Tara and Scott, Karolyn and Lippert, Sandra and Zielinski, Theresa and Mastropasqua, Mauro and Andrighetto, Stefania and Dell'Orto, Patrizia and Renne, Giuseppe and Pruneri, Giancarlo and Dellapasqua, Silvia and Iorfida, Monica and Cancello, Giuseppe and Montagna, Emilia and Cardillo, Anna and Peruzzotti, Giulia and Ghisini, Raffaella and Luini, Alberto and Gentilini, Oreste and Zurrida, Stefano and Curigliano, Giuseppe and Nole, Franco and Orecchia, Roberto and Leonardi, Marisa Cristina and Baratella, Paola and Chifu, Camelia and Sargenti, Manuela and Crivellari, Diana and Morassut, Sandro and Mileto, Mario and Piccoli, Erica and Magri, Marisa Donatella and Buonadonna, Angelo and Candiani, Ezio and Carbone, Antonino and Perin, Tiziana and Volpe, Rachele and Roncadin, Mario and Arcicasa, Mauro and Coran, Francesco and Lagrassa, Manuela and Recalcati, Angelo and Limonta, Maria Emanuela and Tricomi, Paolo and Fenaroli, Privato and Candiago, Elisabetta and Cattaneo, Laura and Gianatti, Alberto and Santini, Donatella and Maweja, Sylvie and Delvenne, Philippe and Rorive, Andrée and Collignon, Joëlle and Garbay, Jean-Remi and Mathieu, Marie-Christine and Galatius, Hanne and Hoffmann, Jack and Schousen, Peer and Lanng, Charlotte and ... and Int Breast Canc Study Grp Trial 23 and International Breast Cancer Study Group Trial 23-01
The Lancet Oncology, ISSN 1470-2045, 10/2018, Volume 19, Issue 10, pp. 1385 - 1393
We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial comparing disease-free survival in patients with breast cancer with one or more... 
SURGERY | WOMEN | MULTICENTER | METASTASIS | ONCOLOGY | LYMPH-NODES | BIOPSY | RECURRENCE | EORTC 10981-22023 AMAROS | Care and treatment | Cancer patients | Breast cancer | Analysis | Surgery
Journal Article
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 08/2019, Volume 121, Issue 4, pp. 325 - 331
BACKGROUND: Chemotherapy-induced alopecia (CIA) is a distressing side effect of cancer therapy. The trial aimed to assess feasibility and effectiveness of... 
WOMEN | IMPACT | ONCOLOGY | HAIR LOSS | DEVICE | EXPERIENCE | QUALITY-OF-LIFE | CARE | Medical devices | Cooling | Baldness | Self evaluation | Feasibility studies | Cooling effects | Clinical trials | Cooling systems | Breast cancer | Cancer therapies | Patients | Side effects | Chemotherapy | Alopecia | Anthracycline | Scalp | Medical electronics | Breast | Self-assessment | Safety
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 12/2010, Volume 124, Issue 3, pp. 689 - 699
Journal Article
European Journal of Gastroenterology & Hepatology, ISSN 0954-691X, 07/2019, Volume 31, Issue 7, pp. 893 - 895
In recent years, the role of atopic dermatitis epidermal skin barrier defects in inducing a transcutaneous allergic sensitization is highly debated, possibly... 
coeliac disease | anaphylaxis | gluten-free diet | wheat allergy | ALLERGEN | GASTROENTEROLOGY & HEPATOLOGY | Medicine, Experimental | Celiac disease | Medical research | Care and treatment
Journal Article
Clinical Breast Cancer, ISSN 1526-8209, 2013, Volume 13, Issue 1, pp. 31 - 39
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 4/2011, Volume 126, Issue 2, pp. 431 - 441
Patients with large ER positive tumors candidate to preoperative chemotherapy may also benefit from a concurrent endocrine intervention, but this issue has... 
Locally advanced breast cancer | Medicine & Public Health | ER positive breast cancer | Premenopausal | Oncology | GnRH analogue | Preoperative treatment | Letrozole | CYCLOPHOSPHAMIDE | PRIMARY SYSTEMIC TREATMENT | TAMOXIFEN | DOXORUBICIN | TUMOR | ENDOCRINE THERAPY | PRIMARY CHEMOTHERAPY | ANASTROZOLE | PHASE-II TRIAL | ONCOLOGY | AROMATASE INHIBITORS | Triazoles - administration & dosage | Receptors, Estrogen - metabolism | Humans | Middle Aged | Gonadotropin-Releasing Hormone - administration & dosage | Receptor, ErbB-2 - metabolism | Ki-67 Antigen - metabolism | Carcinoma, Ductal, Breast - mortality | Gonadotropin-Releasing Hormone - analogs & derivatives | Carcinoma, Lobular - mortality | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Nitriles - administration & dosage | Carcinoma, Lobular - therapy | Adult | Female | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Carcinoma, Ductal, Breast - metabolism | Estradiol - metabolism | Premenopause | Treatment Outcome | Carcinoma, Ductal, Breast - therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Carcinoma, Lobular - metabolism | Women | Pituitary hormones | Menopause | Adjuvant treatment | Neurohormones | Breast cancer | Tamoxifen | Cancer
Journal Article
Clinical Breast Cancer, ISSN 1526-8209, 2015, Volume 15, Issue 4, pp. 259 - 265
Journal Article